{
    "Trade/Device Name(s)": [
        "Spectrolyse PAI-1"
    ],
    "Submitter Information": "American Diagnostica Inc.",
    "510(k) Number": "K063323",
    "Predicate Device Reference 510(k) Number(s)": [
        "K922782"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGP"
    ],
    "Summary Letter Date": "July 27, 2007",
    "Summary Letter Received Date": "July 30, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR864.7290"
    ],
    "Regulation Name(s)": [
        "Test, Qualitative And Quantitative Factor Deficiency"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "Plasminogen Activator Inhibitor Type-1 (PAI-1)"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Colorimetric assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Spectrolyse PAI-1 colorimetric assay for quantitative determination of PAI-1 activity in human plasma",
    "Indications for Use Summary": "Intended for the quantitative determination of Plasminogen Activator Inhibitor Type-1 (PAI-1) activity in human plasma for in vitro diagnostic use",
    "fda_folder": "Hematology"
}